Recommendations for the use of slow-release oral morphine as opioid agonist therapy
Evidence, Guidelines and Recommendations
Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT).
